A 2D-DIGE-based proteomic analysis reveals differences in the platelet releasate composition when comparing thrombin and collagen stimulations

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Vélez, Paula ^a,b,c   Izquierdo, Irene ^a,b,c   Rosa, Isaac ^a,b,c   García, Ángel ^a,b,c  

^a Universidade de Santiago de Compostela ^*  (Spain)

^b Santiago University Clinical Hospital   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COLLAGEN; N3-CYCLOPROPYL-7-((4-(1-METHYLETHYL)PHENYL)METHYL)-7H-PYRROLO(3, 2-F)QUINAZOLINE-1,3-DIAMINE; PROTEIN S; PROTEOME; PYRROLE DERIVATIVE; QUINAZOLINE DERIVATIVE; THROMBIN;

DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOLOGY; METABOLISM; PROTEOMICS; TANDEM MASS SPECTROMETRY; THROMBOCYTE; THROMBOCYTE AGGREGATION; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; UPREGULATION;

ANTIBODIES; BLOOD PLATELETS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLLAGEN; HUMANS; PLATELET AGGREGATION; PROTEIN S; PROTEOME; PROTEOMICS; PYRROLES; QUINAZOLINES; TANDEM MASS SPECTROMETRY; THROMBIN; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; UP-REGULATION;

EID: 84931404378     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08198     Document Type: Article

References (21)

1. Parguiña, A. F., Rosa, I. & García, A. Proteomics applied to the study of plateletrelated diseases: aiding the discovery of novel platelet biomarkers and drug targets. J. Proteomics. 76 Spec No 275-286 (2012).
2. Leslie, M. Beyond clotting: the powers of platelets. Science 328, 562-564 (2010).
3. Coppinger, J. A. et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 103, 2096-2104 (2004).
4. Coppinger, J. A. et al. Moderation of the platelet releasate response by aspirin. Blood 109, 4786-4792 (2007).
5. Della Corta, A. et al. Application of 2-dimensional difference gel electrophoresis (2D-DIGE) to the study of thrombin-activated human platelet secretome. Platelets 19, 43-50 (2008).
6. Piersma et al. Proteomics of the TRAP-induced platelet releasate. J. Proteomics. 72, 91-109 (2009).
7. Jonnalagadda, D., Izu, L. T. & Whiteheart, S. W. Platelet secretion is kinetically heterogeneous in an agonist-responsive manner. Blood 120, 5209-5216 (2012).
8. García, A. Two-dimensional gel electrophoresis in platelet proteomics research. Meth. Mol. Med. 139, 339-353 (2007).
9. Wu, C. C. & Teng, C. M. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation. Eur. J. Pharma. 546, 142-7 (2006).
10. Matsumoto, Y. et al. Highly potent anti-human GPVI monoclonal antibodies derived from GPVI knockout mouse immunization. Thromb. Res. 119, 319-29 (2006).
11. Bendtsen, J. D., Jensen, L. J., Blom, N., Von Heijne, G. & Brunak, S. Feature-based prediction of non-classical and leaderless protein secretion. Protein. Eng. Des. Sel. 17, 349-56 (2004).
12. Di Michele, M. et al. An integrated proteomics and genomics analysis to unravel a heterogeneous platelet secretion defect. Journal of Proteomics. 74, 902-913 (2011).
13. Wijten, P. et al. High Precision Platelet Releasate Definition by Quantitative Reversed Protein Profiling. Arterioscler. Thromb. Vasc. Biol. 33, 1635-8 (2013).
14. Jeimy, S. B. et al. Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation. Thromb. Haemost. 100, 1058-1067 (2008).
15. Dahlbäck, B., Lundwall, A. & Stenflo, J. Primary structure of bovine vitamin Kdependent protein S. Proc. Natl. Acad. Sci. USA. 83, 4199-41203 (1986).
16. Italiano, J. E. Jr. et al Angiogenesis is regulated by a novel mechanism: pro-and antiangiogenic proteins are organized into separate platelet a granules and differentially released. Blood 111, 1227-33 (2008).
17. Battinelli, E. M. et al. Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis. Blood 118, 1359-69 (2011).
18. Biguzzi, E. et al. Molecular diversity and thrombotic risk in protein S deficiency: the PROSIT study. Hum. Mutat. 25, 259-269 (2005).
19. Baumgartner, R. et al. Identification and validation of platelet low biological variation proteins, superior to GAPDH, actin and tubulin, as tools in clinical proteomics. J. Proteomics. 94, 540-51 (2013).
20. Winkler, W. et al. Biological variation of the platelet proteome in the elderly population and its implication for biomarker research. Mol. Cell. Proteomics. 7, 193-203 (2008).
21. Shevchenko, A. et al. Linking genome and proteome bymass spectrometry: largescale identification of yeast proteins from two dimensional gels. Proc. Natl. Acad. Sci. USA. 93, 14440-14445 (1996).